CAR-T cells with the CD38(-)CD73(-)Tim-3(-)HLA-DR(+) phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL. (linkinghub.elsevier.com)

Authors: Mikami T … Takita J Journal: Cell Reports Medicine Published: 2026-02-17 DOI: https://doi.org/10.1016/j.xcrm.2025.102576